Pages that link to "Q28379423"
Jump to navigation
Jump to search
The following pages link to Calcimimetics with potent and selective activity on the parathyroid calcium receptor (Q28379423):
Displaying 50 items.
- Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics (Q34795759) (← links)
- The corpuscles of Stannius, calcium-sensing receptor, and stanniocalcin: responses to calcimimetics and physiological challenges (Q34965548) (← links)
- R990G polymorphism of calcium sensing receptor gene is associated with high parathyroid hormone levels in subjects with vitamin D deficiency: a cross-sectional study (Q35074082) (← links)
- Allosteric activation of plasma membrane receptors—physiological implications and structural origins (Q35121805) (← links)
- Novel treatments for osteoporosis (Q35126745) (← links)
- Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors (Q35143358) (← links)
- Extracellular calcium elicits a chemokinetic response from monocytes in vitro and in vivo (Q35159216) (← links)
- Extracellular calcium sensing and signalling (Q35167960) (← links)
- Utilization of parathyroidectomy for secondary hyperparathyroidism in end-stage renal disease (Q35452299) (← links)
- Structure and function of the human calcium-sensing receptor: insights from natural and engineered mutations and allosteric modulators (Q35459458) (← links)
- The impact of calcimimetics on mineral metabolism and secondary hyperparathyroidism in end-stage renal disease (Q35553312) (← links)
- Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials (Q35571939) (← links)
- A new paradigm for the treatment of secondary hyperparathyroidism (Q35573634) (← links)
- Update on genetic and clinical aspects of primary hyperparathyroidism (Q35583393) (← links)
- Safety of new phosphate binders for chronic renal failure (Q35593901) (← links)
- Extracellular calcium sensing receptor in human pancreatic cells (Q35595102) (← links)
- New concepts in calcium-sensing receptor pharmacology and signalling (Q35657894) (← links)
- Calcium agonists in hyperparathyroidism (Q35688223) (← links)
- An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations. (Q35720141) (← links)
- Inhibition of Excessive Cell Proliferation by Calcilytics in Idiopathic Pulmonary Arterial Hypertension (Q35777179) (← links)
- The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis (Q35826159) (← links)
- The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism. (Q35928870) (← links)
- Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery (Q35952381) (← links)
- Hyperparathyroidism in the elderly patient (Q35999516) (← links)
- Calcium sensing by endocrine cells (Q36004163) (← links)
- The calcium-sensing receptor in normal physiology and pathophysiology: a review (Q36033289) (← links)
- The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport (Q36056698) (← links)
- Cinacalcet HCl: a novel therapeutic for hyperparathyroidism (Q36082068) (← links)
- An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects (Q36173980) (← links)
- Identification of acidic residues in the extracellular loops of the seven-transmembrane domain of the human Ca2+ receptor critical for response to Ca2+ and a positive allosteric modulator (Q36183058) (← links)
- PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor (Q36190666) (← links)
- Calcium sensing by the mammary gland (Q36198187) (← links)
- Clinical potential of GABAB receptor modulators. (Q36358858) (← links)
- Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism. (Q36432849) (← links)
- Keynote review: allosterism in membrane receptors (Q36437496) (← links)
- Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy. (Q36444286) (← links)
- Calcium sensing receptors and calcium oscillations: calcium as a first messenger (Q36510503) (← links)
- Misconceptions about calcimimetics (Q36532586) (← links)
- Minimizing bone abnormalities in children with renal failure (Q36561062) (← links)
- Role of calcium-sensing receptor in mineral ion metabolism and inherited disorders of calcium-sensing. (Q36571114) (← links)
- Medical therapy of secondary hyperparathyroidism in chronic kidney disease: old and new drugs (Q36632228) (← links)
- Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets (Q36662050) (← links)
- Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction. (Q36880126) (← links)
- Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension (Q36963124) (← links)
- Asymmetric synthesis of nonracemic primary amines via spiroborate-catalyzed reduction of pure (E)- and (Z)-O-benzyloximes: applications toward the synthesis of calcimimetic agents (Q37000185) (← links)
- Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens (Q37085969) (← links)
- Calcium and phosphate homeostasis: concerted interplay of new regulators (Q37091865) (← links)
- New strategies for the treatment of hyperparathyroidism incorporating calcimimetics (Q37111857) (← links)
- An Enantiomer of an Oral Small-Molecule TSH Receptor Agonist Exhibits Improved Pharmacologic Properties (Q37127629) (← links)
- The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion (Q37391736) (← links)